来自原的Gly-Pro型DPP-IV抑制:结构-活性关系,抑制动力学和抑制机制
Qiongyao Xu1, Lin Zheng1, Mingtao Huang2
1School of Food Science and Engineering, South China University of Technology, Guangzhou 510640, China; Guangdong Food Green Processing and Nutrition Regulation Technologies Research Center, Guangzhou 510650, China.
Food chemistry
|January 10, 2024
概括
在N3位置上的较小的氨基酸和最佳的长度增强了二二酶IV (DPP-IV) 的抑制. 具有特定相互作用的较短 (5-6个残留物) 增加了DPP-IV抑制活性.
科学领域:
- 生物化学 生物化学
- 药用化学 医学化学
- 计算化学计算化学
背景情况:
- 双基酶IV (DPP-IV) 是2型糖尿病治疗的关键标.
- 以前的研究表明,氨基酸位置和长度会影响Gly-Pro型的DPP-IV抑制活性.
研究的目的:
- 阐明Gly-Pro类型的DPP-IV抑制的分子机制.
- 研究N3氨基酸特性和长度对DPP-IV抑制活性的影响.
主要方法:
- 使用5z尺度描述器进行定量结构-活动关系 (QSAR) 建模.
- 酶动力学测试以确定抑制常量 (Ki).
- 分子对接模拟来分析-DPP-IV相互作用.
主要成果:
- 开发出成功的QSAR模型 (R2=0.830对于三,R2=0.797对于3-12个残留).
- 在N3位置下较低的电友性,极性和侧链量与较高的DPP-IV抑制相关.
- 最佳的长 (5-6个残留物) 增强了与DPP-IV的相互作用,特别是在S2亚位点,减少了乙化,增加了抑制活性.
结论:
- 体长度和N3氨基酸特征对于优化DPP-IV抑制活性至关重要.
- 由序列和长度驱动的DPP-IV亚位点的特定相互作用是强大的抑制的基础.
- 这些发现为设计基于Gly-Pro类型的新型DPP-IV抑制剂提供了基础.
相关概念视频
Dipeptidyl Peptidase 4 Inhibitors
188
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
188
Structural Protein Function
27.7K
Structural proteins are a category of proteins responsible for functions ranging from cell shape and movement to providing support to major structures such as bones, cartilage, hair, and muscles. This group includes proteins such as collagen, actin, myosin, and keratin.
Collagen, the most abundant protein in mammals, is found throughout the body. In connective tissue, such as skin, ligaments, and tendons, it provides tensile strength and elasticity. In bones and teeth, it mineralizes to...
Collagen, the most abundant protein in mammals, is found throughout the body. In connective tissue, such as skin, ligaments, and tendons, it provides tensile strength and elasticity. In bones and teeth, it mineralizes to...
27.7K
Glucagon-like Receptor Agonists
325
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
325
Indirect-Acting Cholinergic Agonists: Mechanism of Action
1.8K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
1.8K
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
567
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
567
Protein-protein Interfaces
12.5K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.5K


